Mbonea Yonazi

Submitted: 25 December 2025 You are already at the latest version Background: Sickle cell disease (SCD) is the most common hemoglobin disorder in the world. Africa has the highest burden of SCD, accounting for up to 75% of the 300,000 annual births of individuals with SCD worldwide. In Tanzania, 11,000 – 14,000 babies are born with SCD each year. Despite treatment advancement, pain is still an attributable cause of admissions among patients with SCD.

• , , , et al., “ A British Society for Haematology Guideline: Diagnosis and Management of Thrombotic Thrombocytopenic Purpura and Thrombotic Microangiopathies ,” British Journal of Haematology , no. ( ): – , https://onlinelibrary.wiley.com/doi/full/10.1111/bjh.19026. • , , , and , “ External Validation of the PLASMIC Score: A Clinical Prediction Tool for Thrombotic Thrombocytopenic Purpura Diagnosis and Treatment ,” Journal of Thrombosis and Haemostasis , no. ( ): /pmc/articles/PMC5760324/.